Valuation: Becton, Dickinson and Company

Market Cap 51.04B 45.59B 42.5B 38.53B 72.51B 4,845B 73.07B 509B 199B 2,520B 192B 187B 8,085B P/E 2026 *
36.1x
P/E 2027 * 20.1x
Enterprise Value 66.92B 59.78B 55.72B 50.52B 95.07B 6,352B 95.82B 668B 261B 3,304B 251B 246B 10,601B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.29x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.13%
1 day-0.80%
1 week+3.92%
Current month+4.68%
1 month+5.35%
3 months+21.80%
6 months+20.55%
Current year-3.45%
1 week 178.9
Extreme 178.9
189.99
1 month 175.71
Extreme 175.71
189.99
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
262.23
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
28/9/26 Sell

Executive/Senior Manager

-76 0.0000%
2/9/26 Tax

Chief Financial Officer

-190 0.0001%
26/8/26 Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+3.92%+0.38%-27.57% 51.04B
+0.78%+4.53%-21.90%+12.92% 178B
+1.17%+6.80%-2.69%+29.25% 119B
-0.02%+1.56%-22.57%+9.57% 108B
+2.29%+2.11%-44.99%-9.58% 75.27B
+1.55%+4.34%+4.14%+74.68% 62.99B
+0.34%+1.05%+19.75%+67.00% 53.46B
-0.69%+0.95%-17.84%+22.09% 40.99B
-1.00%+2.00%+30.46%+11.64% 32.1B
-0.17%+0.42% - - 31.32B
Average +0.08%+2.32%-6.14%+21.11% 75.21B
Weighted average by Cap. +0.10%+3.04%-11.74%+19.77%

Financials

2026 *2027 *
Net sales 19.28B 17.22B 16.05B 14.55B 27.39B 1,830B 27.6B 192B 75.27B 952B 72.4B 70.81B 3,054B 19.74B 17.63B 16.43B 14.9B 28.04B 1,874B 28.26B 197B 77.07B 974B 74.13B 72.5B 3,127B
Net income 1.44B 1.28B 1.2B 1.08B 2.04B 136B 2.06B 14.33B 5.61B 70.92B 5.4B 5.28B 228B 2.34B 2.09B 1.95B 1.77B 3.32B 222B 3.35B 23.34B 9.14B 115B 8.79B 8.59B 371B
Net Debt 15.88B 14.19B 13.23B 11.99B 22.57B 1,508B 22.74B 158B 62.03B 784B 59.66B 58.35B 2,516B 13.95B 12.46B 11.62B 10.53B 19.82B 1,324B 19.98B 139B 54.48B 689B 52.4B 51.25B 2,210B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
13/10/26 US$187.37 -0.80% 1,153,001
12/10/26 US$188.89 +2.80% 1,184,422
09/10/26 US$183.75 +0.55% 1,615,714
08/10/26 US$182.75 +1.44% 1,523,705
07/10/26 US$180.16 -0.08% 1,922,325
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
187.37USD
Average target price
194.08USD
Spread / Average Target
+3.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company